RN7SL740P

Across TCGA pan-cancer cohorts, RN7SL740P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RN7SL740P’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where RN7SL740P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL740P is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.

BLCA, COAD, and LUAD are the cancer types where RN7SL740P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL740P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	III,IV	+0.106	.023	5	view →
COAD	Female	II,III,IV	−0.051	.038	2	view →
LUAD	Male	All	+0.255	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RN7SL740P–BLCA

Open the BLCA breakdown →